BioCatch enters unicorn club as valuation crosses $1 billion in latest secondary deal
"BioCatch, which specializes in software development for identifying and preventing bank fraud and money laundering, achieved unicorn status on the eve of the Hamas-Israel war with the signing of a new secondary deal, according to Calcalist...The company secured around $70 million from Sapphire Ventures at a valuation of over $1 billion in a deal completed one day before Hamas’ murderous attack...The primary shareholder in BioCatch is currently investment fund Bain Capital, which led the last fundraising round in 2020 in which the company raised a total of $145 million. Other notable stakeholders include the investment arms of major global banks such as HSBC, Citi, Barclays, and the investment arm of American Express."